Cirrhosis and liver failure: Induction of systemic oxidative stress leads to brain oedema in portacaval shunted rats

Liver International

Volumn 34, Issue 9, 2014, Pages 1322-1329

  Bosoi, Cristina R ^a   Tremblay, Mélanie ^a   Rose, Christopher F ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Brain oedema; Dimethyl maleate; Hepatic encephalopathy; Oxidative stress; Portacaval shunt

Indexed keywords

AMMONIA; GLUTATHIONE; MALEIC ACID; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; BIOLOGICAL MARKER; DIMETHYL MALEATE; MALEIC ACID DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN WATER; FRONTAL CORTEX; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PORTOCAVAL SHUNT; RAT; ANALYSIS OF VARIANCE; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; COMPLICATION; DRUG EFFECTS; END STAGE LIVER DISEASE; HEPATIC ENCEPHALOPATHY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

AMMONIA; ANALYSIS OF VARIANCE; ANIMALS; BIOLOGICAL MARKERS; BRAIN EDEMA; END STAGE LIVER DISEASE; GLUTATHIONE; HEPATIC ENCEPHALOPATHY; MALE; MALEATES; MALONDIALDEHYDE; OXIDATIVE STRESS; PORTACAVAL SHUNT, SURGICAL; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 84908229620     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12414     Document Type: Article

References (52)

1. Bajaj JS. Review article: the modern management of hepatic encephalopathy. Aliment Pharmacol Ther 2010; 31:537-47.
2. Ćordoba J. New assessment of hepatic encephalopathy. J Hepatol 2011; 54: 1030-40.
3. Bajaj JS, Wade JB, Sanyal AJ. Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy. Hepatology 2009; 50: 2014-21.
4. Hartmann IJ, Groeneweg M, Quero JC, et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000; 95: 2029-34.
5. Bosoi CR, Rose CF. Brain edema in acute liver failure and chronic liver disease: similarities and differences. Neurochem Int 2013; 62: 446-57.
6. Rovira A, Mínguez B, Aymerich FX, et al. Decreased white matter lesion volume and improved cognitive function after liver transplantation. Hepatology 2007; 46: 1485-90.
7. Shah NJ, Neeb H, Kircheis G, et al. Quantitative cerebral water content mapping in hepatic encephalopathy. Neuroimage 2008; 41: 706-17.
8. Sugimoto R, Iwasa M, Maeda M, et al. Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy. Am J Gastroenterol 2008; 103:1413-20.
9. Bosoi CR, Parent-Robitaille C, Anderson K, Tremblay M, Rose CF. AST-120 (spherical carbon adsorbent) lowers ammonia levels and attenuates brain edema in bile ductligated rats. Hepatology 2011; 53: 1995-2002.
10. Davies NA, Wright G, Ytrebø LM, et al. L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats. Hepatology 2009; 50: 155-64.
11. Wright G, Davies NA, Shawcross DL, et al. Endotoxemia produces coma and brain swelling in bile duct ligated rats. Hepatology 2007; 45: 1517-26.
12. Erceg S, Monfort P, Hernández-Viadel M, et al. Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts. Hepatology 2005; 41: 299-306.
13. Cauli O, Rodrigo R, Piedrafita B, et al. Neuroinflammation contributes to hypokinesia in rats with hepatic encephalopathy: ibuprofen restores its motor activity. J Neurosci Res 2009; 87: 1369-74.
14. Lodi R, Tonon C, Stracciari A, et al. Diffusion MRI shows increased water apparent diffusion coefficient in the brains of cirrhotics. Neurology 2004; 62: 762-6.
15. Kale RA, Gupta RK, Saraswat VA, et al. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 2006; 43: 698-706.
16. Zhang L, Qi R, Wu S, et al. Brain default-mode network abnormalities in hepatic encephalopathy: a resting-state functional MRI study. Hum Brain Mapp 2012; 33: 1384-92.
17. Ong JP, Aggarwal A, Krieger D, et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med 2003; 114: 188-93.
18. Kundra A, Jain A, Banga A, Bajaj G, Kar P. Evaluation of plasma ammonia levels in patients with acute liver failure and chronic liver disease and its correlation with the severity of hepatic encephalopathy and clinical features of raised intracranial tension. Clin Biochem 2005; 38: 696-9.
19. He Y, Li G, Song H, et al. Partial pressure of NH in cirrhotic patients with and without hepatic encephalopathy. J Gastrointest Liver Dis 2011; 20: 169-74.
20. Nicolao F, Efrati C, Masini A, et al. Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy. J Hepatol 2003; 38:441-6.
21. Weissenborn K, Ahl B, Fischer-Wasels D, et al. Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy. Gut 2007; 56: 1736-42.
22. Seyan AS, Hughes RD, Shawcross DL. Changing face of hepatic encephalopathy: role of inflammation and oxidative stress. World J Gastroenterol 2010; 16: 3347-57.
23. Bosoi CR, Rose CF. Oxidative stress: a systemic factor implicated in the pathogenesis of hepatic encephalopathy. Metab Brain Dis 2013; 28: 175-8.
24. Chen M-F, Mo L-R, Lin R-C, et al. Increase of resting levels of superoxide anion in the whole blood of patients with decompensated liver cirrhosis. Free Radic Biol Med 1997; 23: 672-9.
25. Spahr L, Bresson-Hadni S, Amann P, et al. Allopurinol, oxidative stress and intestinal permeability in patients with cirrhosis: an open-label pilot study. Liver Int 2007; 27:54-60.
26. Battelli MG, Musiani S, Valgimigli M, et al. Serum xanthine oxidase in human liver disease. Am J Gastroenterol 2001; 96: 1194-9.
27. Bosoi CR, Yang X, Huynh J, et al. Systemic oxidative stress is implicated in the pathogenesis of brain edema in rats with chronic liver failure. Free Radic Biol Med 2012; 52:1228-35.
28. Townsend DM, Tew KD, Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother 2003; 57: 145-55.
29. Burgunder JM, Lauterburg BH. Decreased production of glutathione in patients with cirrhosis. Eur J Clin Invest 1987; 17: 408-14.
30. Butterworth RF, Norenberg MD, Felipo V, et al. Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int 2009; 29: 783-8.
31. Yang X, Bosoi CR, Jiang W, Tremblay M, Rose CF. Portacaval anastomosis-induced hyperammonemia does not lead to oxidative stress. Metab Brain Dis 2010; 25: 11-5.
32. Agarwal R, Shukla GS. Potential role of cerebral glutathione in the maintenance of blood-brain barrier integrity in rat. Neurochem Res 1999; 24: 1507-14.
33. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
34. Marmarou A, Poll W, Shulman K, Bhagavan H. A simple gravimetric technique for measurement of cerebral edema. J Neurosurg 1978; 49: 530-7.
35. Ergün Y, Kurutaş EB, Ozdil B, Güneşaçar R, Ergün Y. Evaluation of nitrite/nitrate levels in relation to oxidative stress parameters in liver cirrhosis. Clin Res Hepatol Gastroenterol 2011; 35: 303-8.
36. Weber CA, Duncan CA, Lyons MJ, Jenkinson SG. Depletion of tissue glutathione with diethyl maleate enhances hyperbaric oxygen toxicity. Am J Physiol 1990; 258: L308-12.
37. Montoliu C, Cauli O, Urios A, et al. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis. Am J Gastroenterol 2011; 106: 1629-37.
38. Ljubuncic P, Tanne Z, Bomzon A. Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease. Gut 2000; 47: 710-6.
39. Murthy CR, Rama Rao KV, Bai G, Norenberg MD. Ammonia-induced production of free radicals in primary cultures of rat astrocytes. J Neurosci Res 2001; 66: 282-8.
40. Jayakumar AR, Panickar KS, Murthy CRK, Norenberg MD. Oxidative stress and mitogen-activated protein kinase phosphorylation mediate ammonia-induced cell swelling and glutamate uptake inhibition in cultured astrocytes. J Neurosci 2006; 26: 4774-84.
41. Kosenko E, Kaminsky Y, Kaminsky A, et al. Superoxide production and antioxidant enzymes in ammonia intoxication in rats. Free Radic Res 1997; 27: 637-44.
42. Kosenko E, Venediktova N, Kaminsky Y, Montoliu C, Felipo V. Sources of oxygen radicals in brain in acute ammonia intoxication in vivo. Brain Res 2003; 981: 193-200.
43. Görg B, Qvartskhava N, Keitel V, et al. Ammonia induces RNA oxidation in cultured astrocytes and brain in vivo. Hepatology 2008; 48: 567-79.
44. Mehrotra A, Trigun SK. Moderate grade hyperammonemia induced concordant activation of antioxidant enzymes is associated with prevention of oxidative stress in the brain slices. Neurochem Res 2012; 37: 171-81.
45. Schliess F, Görg B, Fischer R, et al. Ammonia induces MK-801-sensitive nitration and phosphorylation of protein tyrosine residues in rat astrocytes. FASEB J 2002; 16:739-41.
46. Singh S, Koiri RK, Trigun SK. Acute and chronic hyperammonemia modulate antioxidant enzymes differently in cerebral cortex and cerebellum. Neurochem Res 2008; 33:103-13.
47. Jiang W, Desjardins P, Butterworth RF. Hypothermia attenuates oxidative/nitrosative stress, encephalopathy and brain edema in acute (ischemic) liver failure. Neurochem Int 2009; 55: 124-8.
48. Görg B, Qvartskhava N, Bidmon H-J, et al. Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy. Hepatology 2010; 52: 256-65.
49. Pun PBL, Lu J, Moochhala S. Involvement of ROS in BBB dysfunction. Free Radic Res 2009; 43: 348-64.
50. Butterworth RF. The liver-brain axis in liver failure: neuroinflammation and encephalopathy. Nat Rev Gastroenterol Hepatol 2013; 10: 522-8.
51. Cauli O, Rodrigo R, Piedrafita B, Boix J, Felipo V. Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts. Hepatology 2007; 46: 514-9.
52. Perazzo JC. Hepatic encephalopathy: an approach to its multiple pathophysiological features. World J Hepatol 2012; 4: 50.